Join us to celebrate the achievements of the 60 impactful analytical scientists featured in the 2024 Power List.
09/06/2013 | Rich Whitworth
The discussion thread on an opinion article on chemometrics has been incredibly insightful – and spurred our commissioning strategy.
07/24/2013 | Rich Whitworth
Richard D. Smith reflects on 40 years in mass spectrometry following his Distinguished Contribution award at ASMS 2013.
07/23/2013 | Rich Whitworth
Founded by frustrated student Mark Hahnel in 2011, figshare has blossomed to offer a cloud-based publishing solution to otherwise wasted research outputs
The talk of TED but a few months ago, uChek, an iPhone-based urinalysis system, came almost immediately under fire from the FDA. There’s an app(roval) for that…
A discussion with Dreyfus Prize winner R. Graham Cooks. It has been a very good year for visionary mass spectrometrists.
An integrated approach to uncovering distinct metabolite profile shifts in diabetes progression. The prevalence of type 2 diabetes mellitus (T2DM) is on a rampant rise across the globe, making it a critical area of study for metabolomics and biomarker discovery.
A global, online risk-assessment tool offers a more intelligent way to protect against emerging food fraud and contamination
07/22/2013 | Rich Whitworth
A new biosensor cradle and app take us one step closer to portable and more universal analytical access. Researchers at the University of Illinois have developed a cradle accessory for the iPhone that aligns its integral camera with a series of optical components to analyze a primed slide.
06/10/2013 | Rich Whitworth
Generating robust biomolecular signatures from diabetic wound fluid
How hundreds of extracellular signaling proteins secreted during immune responses were ... discovered – and what it tells us about the whisperered conversations between cells
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
A Voyage of Diagnostic Discovery
The Analytical Scientist Innovation Awards 2024: #1
“A Turning Point in Translational Medicine”